Faster access than browser!Similarities between Ketamine and Rapastinel
Ketamine and Rapastinel have 19 things in common (in Unionpedia): Agonist, Allosteric modulator, Allosteric regulation, Analgesic, Antidepressant, Apimostinel, Binding selectivity, Intravenous therapy, Ligand (biochemistry), Major depressive disorder, Mechanism of action, Medication, NMDA receptor, NMDA receptor antagonist, Oral administration, Partial agonist, Receptor antagonist, Structural analog, Treatment-resistant depression.
Agonist
An agonist is a chemical that binds to a receptor and activates the receptor to produce a biological response.
Agonist and Ketamine · Agonist and Rapastinel ·
Allosteric modulator
In biochemistry and pharmacology, an allosteric modulator (allo- from the Greek meaning "other") is a substance which indirectly influences (modulates) the effects of a primary ligand that directly activates or deactivates the function of a target protein.
Allosteric modulator and Ketamine · Allosteric modulator and Rapastinel ·
Allosteric regulation
In biochemistry, allosteric regulation (or allosteric control) is the regulation of an enzyme by binding an effector molecule at a site other than the enzyme's active site.
Allosteric regulation and Ketamine · Allosteric regulation and Rapastinel ·
Analgesic
An analgesic or painkiller is any member of the group of drugs used to achieve analgesia, relief from pain.
Analgesic and Ketamine · Analgesic and Rapastinel ·
Antidepressant
Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.
Antidepressant and Ketamine · Antidepressant and Rapastinel ·
Apimostinel
Apimostinel (former developmental code name NRX-1074) is an antidepressant, acting as a selective partial agonist of an allosteric site of the glycine site of the NMDA receptor complex, which is under investigation by Naurex and Allergan for the treatment of major depressive disorder (MDD).
Apimostinel and Ketamine · Apimostinel and Rapastinel ·
Binding selectivity
Binding selectivity is defined with respect to the binding of ligands to a substrate forming a complex.
Binding selectivity and Ketamine · Binding selectivity and Rapastinel ·
Intravenous therapy
Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).
Intravenous therapy and Ketamine · Intravenous therapy and Rapastinel ·
Ligand (biochemistry)
In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.
Ketamine and Ligand (biochemistry) · Ligand (biochemistry) and Rapastinel ·
Major depressive disorder
Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.
Ketamine and Major depressive disorder · Major depressive disorder and Rapastinel ·
Mechanism of action
In pharmacology, the term mechanism of action (MOA) refers to the specific biochemical interaction through which a drug substance produces its pharmacological effect.
Ketamine and Mechanism of action · Mechanism of action and Rapastinel ·
Medication
A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease.
Ketamine and Medication · Medication and Rapastinel ·
NMDA receptor
The N-methyl-D-aspartate receptor (also known as the NMDA receptor or NMDAR), is a glutamate receptor and ion channel protein found in nerve cells.
Ketamine and NMDA receptor · NMDA receptor and Rapastinel ·
NMDA receptor antagonist
NMDA receptor antagonists are a class of anesthetics that work to antagonize, or inhibit the action of, the ''N''-Methyl-D-aspartate receptor (NMDAR).
Ketamine and NMDA receptor antagonist · NMDA receptor antagonist and Rapastinel ·
Oral administration
| name.
Ketamine and Oral administration · Oral administration and Rapastinel ·
Partial agonist
In pharmacology, partial agonists are drugs that bind to and activate a given receptor, but have only partial efficacy at the receptor relative to a full agonist.
Ketamine and Partial agonist · Partial agonist and Rapastinel ·
Receptor antagonist
A receptor antagonist is a type of receptor ligand or drug that blocks or dampens a biological response by binding to and blocking a receptor rather than activating it like an agonist.
Ketamine and Receptor antagonist · Rapastinel and Receptor antagonist ·
Structural analog
A structural analog, also known as a chemical analog or simply an analog, is a compound having a structure similar to that of another compound, but differing from it in respect to a certain component.
Ketamine and Structural analog · Rapastinel and Structural analog ·
Treatment-resistant depression
Treatment-resistant depression (TRD) or treatment-refractory depression is a term used in clinical psychiatry to describe cases of major depressive disorder (MDD) that do not respond adequately to appropriate courses of at least two antidepressants.
Ketamine and Treatment-resistant depression · Rapastinel and Treatment-resistant depression ·
The list above answers the following questions
- What Ketamine and Rapastinel have in common
- What are the similarities between Ketamine and Rapastinel
Ketamine and Rapastinel Comparison
Ketamine has 386 relations, while Rapastinel has 48. As they have in common 19, the Jaccard index is 4.38% = 19 / (386 + 48).
References
This article shows the relationship between Ketamine and Rapastinel. To access each article from which the information was extracted, please visit:
